683 Capital Management’s Adverum Biotechnologies ADVM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-10,000
| Closed | -$95K | – | 298 |
|
|
2022
Q3 | $95K | Sell |
10,000
-10,686
| -52% | -$102K | 0.01% | 154 |
|
|
2022
Q2 | $248K | Buy |
20,686
+10,686
| +107% | +$128K | 0.02% | 164 |
|
|
2022
Q1 | $131K | Hold |
10,000
| – | – | 0.01% | 274 |
|
|
2021
Q4 | $176K | Sell |
10,000
-10,000
| -50% | -$176K | 0.01% | 271 |
|
|
2021
Q3 | $434K | Buy |
+20,000
| New | +$434K | 0.02% | 149 |
|
|
2019
Q3 | – | Sell |
-35,899
| Closed | -$4.27M | – | 137 |
|
|
2019
Q2 | $4.27M | Sell |
35,899
-340
| -0.9% | -$40.4K | 0.39% | 40 |
|
|
2019
Q1 | $1.9M | Hold |
36,239
| – | – | 0.17% | 59 |
|
|
2018
Q4 | $1.14M | Buy |
36,239
+33,385
| +1,170% | +$1.05M | 0.07% | 73 |
|
|
2018
Q3 | $173K | Buy |
+2,854
| New | +$173K | 0.01% | 103 |
|
|
2018
Q1 | – | Sell |
-55,000
| Closed | -$1.93M | – | 123 |
|
|
2017
Q4 | $1.93M | Hold |
55,000
| – | – | 0.16% | 63 |
|
|
2017
Q3 | $2.01M | Buy |
55,000
+12,500
| +29% | +$456K | 0.21% | 56 |
|
|
2017
Q2 | $1.06M | Buy |
42,500
+7,500
| +21% | +$188K | 0.16% | 59 |
|
|
2017
Q1 | $945K | Buy |
35,000
+10,000
| +40% | +$270K | 0.15% | 55 |
|
|
2016
Q4 | $725K | Buy |
+25,000
| New | +$725K | 0.05% | 51 |
|